Nerve and Vascular Biomarkers in Skin Biopsies Differentiate Painful From Painless Peripheral Neuropathy in Type 2 Diabetes

被引:11
作者
Shillo, Pallai [1 ]
Yiangou, Yiangos [2 ]
Donatien, Philippe [2 ]
Greig, Marni [1 ]
Selvarajah, Dinesh [1 ]
Wilkinson, Iain D. [3 ]
Anand, Praveen [2 ]
Tesfaye, Solomon [1 ]
机构
[1] Sheffield Teaching Hosp NHS Fdn Trust, Diabet Res Unit, Sheffield, England
[2] Imperial Coll London, Hammersmith Hosp, Peripheral Neuropathy Unit, London, England
[3] Univ Sheffield, Acad Unit Radiol, Sheffield, England
来源
FRONTIERS IN PAIN RESEARCH | 2021年 / 2卷
关键词
pain; biomarkers; skin; vascular; painful diabetic neuropathy; von Willebrand Factor; IENFD; type; 2; diabetes; VON-WILLEBRAND-FACTOR; GROWTH-FACTOR; POLYNEUROPATHY; DYSFUNCTION; REGENERATION; NOCICEPTION; MECHANISMS; ALLODYNIA; PHENOTYPE; DIAGNOSIS;
D O I
10.3389/fpain.2021.731658
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Painful diabetic peripheral neuropathy can be intractable with a major impact, yet the underlying pain mechanisms remain uncertain. A range of neuronal and vascular biomarkers was investigated in painful diabetic peripheral neuropathy (painful-DPN) and painless-DPN and used to differentiate painful-DPN from painless-DPN. Skin biopsies were collected from 61 patients with type 2 diabetes (T2D), and 19 healthy volunteers (HV). All subjects underwent detailed clinical and neurophysiological assessments. Based on the neuropathy composite score of the lower limbs [NIS(LL)] plus seven tests, the T2D subjects were subsequently divided into three groups: painful-DPN (n = 23), painless-DPN (n = 19), and No-DPN (n = 19). All subjects underwent punch skin biopsy, and immunohistochemistry used to quantify total intraepidermal nerve fibers (IENF) with protein gene product 9.5 (PGP9.5), regenerating nerve fibers with growth-associated protein 43 (GAP43), peptidergic nerve fibers with calcitonin gene-related peptide (CGRP), and blood vessels with von Willebrand Factor (vWF). The results showed that IENF density was severely decreased (p < 0.001) in both DPN groups, with no differences for PGP9.5, GAP43, CGRP, or GAP43/PGP9.5 ratios. There was a significant increase in blood vessel (vWF) density in painless-DPN and No-DPN groups compared to the HV group, but this was markedly greater in the painful-DPN group, and significantly higher than in the painless-DPN group (p < 0.0001). The ratio of sub-epidermal nerve fiber (SENF) density of CGRP:vWF showed a significant decrease in painful-DPN vs. painless-DPN (p = 0.014). In patients with T2D with advanced DPN, increased dermal vasculature and its ratio to nociceptors may differentiate painful-DPN from painless-DPN. We hypothesized that hypoxia-induced increase of blood vessels, which secrete algogenic substances including nerve growth factor (NGF), may expose their associated nociceptor fibers to a relative excess of algogens, thus leading to painful-DPN.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] Vascular and nerve biomarkers in thigh skin biopsies differentiate painful from painless diabetic peripheral neuropathy
    Sloan, Gordon
    Donatien, Philippe
    Privitera, Rosario
    Shillo, Pallai
    Caunt, Sharon
    Selvarajah, Dinesh
    Anand, Praveen
    Tesfaye, Solomon
    FRONTIERS IN PAIN RESEARCH, 2024, 5
  • [2] Painful neuropathy with trigeminal nerve involvement in type 2 diabetes
    Takayama, S
    Osawa, M
    Takahashi, Y
    Iwamoto, Y
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2006, 34 (01) : 115 - 118
  • [3] Patterns of cutaneous nerve fibre loss and regeneration in type 2 diabetes with painful and painless polyneuropathy
    Boenhofl, Gidon J.
    Strom, Alexander
    Puettgen, Sonja
    Ringel, Bernd
    Brueggemann, Jutta
    Bodis, Kalman
    Muessig, Karsten
    Szendroedi, Julia
    Roden, Michael
    Ziegler, Dan
    DIABETOLOGIA, 2017, 60 (12) : 2495 - 2503
  • [4] Prevalence and Determinants of Painful and Painless Neuropathy in Type 1 Diabetes Mellitus
    Barbosa, Margarida
    Saavedra, Ana
    Oliveira, Sofia
    Reis, Ligia
    Rodrigues, Filipa
    Severo, Milton
    Sittl, Reinhard
    Maier, Christoph
    Carvalho, Davide M.
    FRONTIERS IN ENDOCRINOLOGY, 2019, 10
  • [5] Association of reduced glyoxalase 1 activity and painful peripheral diabetic neuropathy in type 1 and 2 diabetes mellitus patients
    Skapare, Elina
    Konrade, Ilze
    Liepinsh, Edgars
    Strele, Ieva
    Makrecka, Marina
    Bierhaus, Angelika
    Lejnieks, Aivars
    Pirags, Valdis
    Dambrova, Maija
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2013, 27 (03) : 262 - 267
  • [6] Impaired Vascular Endothelial Function is Associated with Peripheral Neuropathy in Patients with Type 2 Diabetes
    Li, Lingling
    Yang, Ying
    Bai, Jia
    Zhang, Yangyang
    Yang, Hong
    Zhang, Yuqi
    Lv, Haihong
    DIABETES METABOLIC SYNDROME AND OBESITY, 2022, 15 : 1437 - 1449
  • [7] Prevalence of painful diabetic peripheral neuropathy in type 2 diabetes mellitus and diabetic peripheral neuropathy: A nationwide cross-sectional study in mainland China
    Li, Chenxi
    Wang, Weimin
    Ji, Qiuhe
    Ran, Xingwu
    Kuang, Hongyu
    Yu, Xuefeng
    Fang, Hui
    Yang, Jing
    Liu, Jing
    Xue, Yaoming
    Feng, Bo
    Lei, Minxiang
    Zhu, Dalong
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2023, 198
  • [8] Prevalence and clinical implications of painful diabetic peripheral neuropathy in type 2 diabetes: Results from a nationwide hospital-based study of diabetic neuropathy in Korea
    Kim, Sang Soo
    Won, Jong Chul
    Kwon, Hyuk Sang
    Kim, Chong Hwa
    Lee, Ji Hyun
    Park, Tae Sun
    Ko, Kyung Soo
    Cha, Bong Yun
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2014, 103 (03) : 522 - 529
  • [9] Nerve growth factor/p38 signaling increases intraepidermal nerve fiber densities in painful neuropathy of type 2 diabetes
    Cheng, Hsinlin T.
    Dauch, Jacqueline R.
    Hayes, John M.
    Yanik, Brandon M.
    Feldman, Eva L.
    NEUROBIOLOGY OF DISEASE, 2012, 45 (01) : 280 - 287
  • [10] Glycemic variability's impact on painful diabetic peripheral neuropathy in type 2 diabetes patients
    Chang, Kuo-Cheng
    Pai, Yen-Wei
    Lin, Ching-Heng
    Lee, I-Te
    Chang, Ming-Hong
    SCIENTIFIC REPORTS, 2024, 14 (01):